Damon DeSantis - 18 Jun 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Damon DeSantis
Issuer symbol
INBP
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 14:12:14 UTC
Previous filing
04 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeSantis Damon Director 2424 N FEDERAL HIGHWAY, SUITE 208, BOCA RATON /s/ Damon DeSantis 20 Jun 2025 0001889279

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 18 Jun 2025 Common Stock 50,000 $0.3000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.